Certara Expands Biosimulation Market with AI-Driven QSP Platform
Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution.
QSP has rapidly become a cornerstone of modern drug discovery and development with QSP-based FDA submissions having nearly doubled every 1.4 years since 2013.
QSP combines computational modeling and experimental data to examine how a drug interacts with biological systems and disease processes, enabling scientists to predict critical outcomes such as optimal dosing, therapeutic window, and ideal patient populations.
“Certara IQ represents the next step in making biosimulation a foundational capability across the entire drug discovery and development value chain,”
said William F.
Author summary: Certara launches AI-driven QSP platform.
More News
- Funny Scenes! Tim David & Varun Chakravarthy Share Hilarious Standoff Moment During IND Vs AUS 2nd T20 Match; Video
- Ayuba Sylvester James: “For MCP to Rise, Chakwera Must Fall” - Malawi Nyasa Times - News from Malawi about Malawi
- Amazon shares surge as AWS rebounds, AI demand lifts outlook | The Express Tribune
- Hazlewood shines as Australia crush India by four wickets - OrissaPOST
- Norris Praised for His Character: "That’s Actually a Superpower"
- Florence + The Machine - Everybody Scream Review
- 10 tracks that prove MF DOOM was the master of samples
- Why is the Google Doodle Pac-Man themed? | LBC
- Megyn Kelly criticises Sydney Sweeney’s sheer gown at Variety Power of Women event | The Express Tribune
- MEG takeover vote postponed again over questions about Cenovus-Strathcona side deal